NEW YORK, May 5, 2017 /PRNewswire/ -- A Missouri jury has ordered Johnson & Johnson and Imery's Talc to pay $110.5 million to a Virginia woman who developed ovarian cancer following years of genital talcum powder use. Yesterday's verdict followed 10 hours of deliberations and was the largest rendered so far in the consolidated talcum powder litigation currently underway in Missouri's 22nd Circuit Court for the City of St. Louis. (Case No. No. 1422-CC09326-01)
"Our Firm is representing a number of clients who also claim to have developed ovarian cancer following the long-term use of Johnson & Johnson's Baby Powder and Shower-to-Shower products for feminine hygiene purposes. We are extremely pleased with this verdict and will continue to monitor upcoming talcum powder trials for any developments that might affect our clients' cases," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer that may be associated with Johnson & Johnson's talc-based powders.
Talcum Powder Litigation
According to her lawsuit, Lois Slemp had used Johnson & Johnson's talcum powders for routine feminine hygiene for more than 40 years. The now 61-year-old Plaintiff was diagnosed with ovarian cancer in 2012, which has since spread to her liver. During the three-week trial, Slemp's attorneys highlighted several Johnson & Johnson internal documents which they said proved company officials had long been aware of research linking genital talc use to an increased risk of ovarian cancer. Slemp asserted that Johnson & Johnson's failure to warn consumer of this danger was motivated by a desire to protect profits derived from its talcum powder products.
After finding that Johnson & Johnson and talc supplier Imery's were negligent in failing to adequately warn the public of the dangers potentially associated with talc-based products, jurors awarded Slemp $5.4 million in compensatory damage. The jury found Johnson & Johnson 99% liable and ordered the company to pay $104 million in punitive damages. Imery's was assessed $50,000 in damages.
Plaintiffs in three other Missouri talcum powder trials have been awarded compensatory and punitive damages amounting to $70 million, $72 million and $55 million. Johnson & Johnson's only win came in a case that concluded in March.
Women who were diagnosed with ovarian cancer following the long-term use of talc-based products for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2017 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Sandy A. Liebhard, Esq.
Bernstein Liebhard LLP
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/johnson--johnson-loses-another-talcum-powder-lawsuit-as-missouri-jury-awards-more-than-110-million-to-ovarian-cancer-victim-bernstein-liebhard-llp-reports-300452409.html
SOURCE Bernstein Liebhard LLP